Cargando…
High serum C-reactive protein levels predict survival in patients with treated advanced lung adenocarcinoma
BACKGROUND: The prognosis of non-small cell lung cancer (NSCLC) varies greatly depending on whether or not it can receive molecular-targeted drug treatment including epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). We investigated the clinical utility of C-reactive protein...
Autores principales: | Hotta, Takamasa, Nakashima, Kazuhisa, Hata, Kojiro, Tsubata, Yukari, Isobe, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024849/ https://www.ncbi.nlm.nih.gov/pubmed/33841940 http://dx.doi.org/10.21037/jtd-20-3123 |
Ejemplares similares
-
Acute Interstitial Lung Disease Induced by Rechallenge with Ceritinib
por: Hotta, Takamasa, et al.
Publicado: (2019) -
Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas
por: Hotta, Takamasa, et al.
Publicado: (2020) -
Clinical Management of Asthma by Respiratory Specialists versus General Practitioners: Questionnaire Survey Results Over 6 Years
por: Hamaguchi, Megumi, et al.
Publicado: (2021) -
Reproducible abscopal effect in a patient with lung cancer who underwent whole‐brain irradiation and atezolizumab administration
por: Hotta, Takamasa, et al.
Publicado: (2021) -
Multiple Mass Lesions in Pneumocystis Pneumonia
por: Kobayashi, Misato, et al.
Publicado: (2022)